WO2022081120A1 - A method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites and viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body - Google Patents

A method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites and viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body Download PDF

Info

Publication number
WO2022081120A1
WO2022081120A1 PCT/TR2021/051047 TR2021051047W WO2022081120A1 WO 2022081120 A1 WO2022081120 A1 WO 2022081120A1 TR 2021051047 W TR2021051047 W TR 2021051047W WO 2022081120 A1 WO2022081120 A1 WO 2022081120A1
Authority
WO
WIPO (PCT)
Prior art keywords
plasma
circuit
environment
created
chloride
Prior art date
Application number
PCT/TR2021/051047
Other languages
French (fr)
Inventor
Serkan TUNÇ
Sevil TUNÇ
Original Assignee
Tunc Serkan
Tunc Sevil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tunc Serkan, Tunc Sevil filed Critical Tunc Serkan
Publication of WO2022081120A1 publication Critical patent/WO2022081120A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Definitions

  • This invention is related to a method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current without adding any chemicals or performing any additional procedure through the blood plasma taken from the human and animal body infected by organisms such as viruses, bacteria, fungi, parasites etc. as serum to a living body.
  • This invention to be registered intends to create chemical reactions inside the plasma by the passage of electric current through the blood plasma taken from human and animal body infected by organisms such as viruses, bacteria, fungi, parasites etc. and thus, allow the plasma to build immunity by deactivating organisms in the plasma such as viruses, bacteria, fungi, parasites etc. Therefore, the plasma acquires a structure that can build immunity in human and animal body and can be administered to human and animal body.
  • Figure 1 The flow chart of the method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body.
  • 3OO.A As a result of supplying current to the said circuit until it reaches the desired level, dissociation of water (H2O) into hydrogen (H + ) and hydroxide (OH ), sodium chloride (NaCl) into (Na + ) and chloride (Cl ) and potassium chloride (KC1) into potassium (K + ) and chloride (Cl )
  • HOC1 hypochlorous acid
  • OCT hypochlorite
  • the invention is a circuit configuration created by using the human or animal plasma as a type of resistance.
  • the said circuit is configured by the series connection of a direct current generator which converts alternating current into direct current, an electrical frequency generator, the human or animal blood plasma which contacts electrodes in a closed insulated nonconductive container, an on/off switch and the said components together with a conductor wire.
  • the circuit that is created to achieve the purpose of the invention has a direct current electric generator which converts alternating current into direct current.
  • the electrical frequency generator is integrated with a series connection to the direct current electric generator to create a frequency in direct current.
  • the said circuit has at least one switch that turns the circuit on and off to control the flow of current.
  • the human or animal blood plasma is connected in series to the circuit as resistance to create current intensity in the circuit.
  • the frequency generator that gives the current coming from the direct current generator its frequency character and is connected in series to the circuit, is added to the circuit by connecting to the output of the direct current electric generator.
  • Hypochlorite (OCT) ion is created by the bonding of chloride (Cl ) ions created by supplying current to the circuit with oxygen (O) present in dissolved form in the same environment.
  • Hypochlorous acid (HOC1) is created by the bonding of hydrogen (H + ) created by supplying current to the circuit with hypochlorite (OC1 ).
  • Sodium hydroxide (NaOH) is created by the bonding of sodium (Na + ) created by supplying current to the circuit with hydroxide (OH ).
  • Potassium hydroxide (KOH) is created by the bonding of potassium (K + ) created by supplying current to the circuit with hydroxide (OH ).
  • Sodium hydroxide (NaOH) and potassium hydroxide (KOH) created by supplying current to the circuit dissolve the lipid bilayer of the viruses in the plasma, allowing for the breaking up of the virus bilayer and dissipating the spike proteins which give the virus its infectious character on the bilayer to the environment.
  • Sodium hydroxide (NaOH) and potassium hydroxide (KOH) created by supplying current to the circuit dissolves the cell membranes of bacteria, fungi and parasites which have a lipid bilayer as cell membrane present in the plasma.
  • Hypochlorous acid (HOC1) and hypochlorite (OCT) created by supplying current to the circuit disrupt the cell wall and cytoplasm of bacteria, fungi and parasites present in the plasma, dissipating genetic materials into the environment.
  • Hypochlorous acid (HOC1) and hypochlorite (OC1 ) created by supplying current to the circuit dissolve the capsid protein of the viruses the lipid bilayer of which is dissolved and dissipate genetic materials into the plasma environment.
  • Immunity is developed by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment. Immunity is developed by administering the said plasma to the body intra venal and introducing it to the components of the immunity system.
  • the method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites and viruses etc. in the blood plasma after the passage of electric current as serum to the body comprises of the following procedural steps:
  • hypochlorous acid HOC1
  • OCT hypochlorite
  • the invention is a method used in treatment of humans or animals and can easily be applied to the industry.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention is related to a method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body, and comprises the procedural steps of creating a circuit configuration through the series connection of a direct current electric generator, an electrical frequency generator, the human or animal blood plasma which functions as a variable resistance module, an on/off switch and the said components together with a conductor wire (100), supplying current to the said circuit until it reaches an energy level that exceeds the molecular bond dissociation energy of water (H2O) and salts of sodium chloride (NaCl) and potassium chloride (KCl) present in the plasma (200), as a result of supplying current to the said circuit until it reaches the desired level, dissociation of water (H2O) into hydrogen (H+) and hydroxide (OH-), sodium chloride (NaCl) into (Na+) and chloride (Cl-) and potassium chloride (KCl) into potassium (K+) and chloride (Cl-) (300), creating hypochlorite (OCl-) ion, hypochlorous acid (HOCl), sodium hydroxide (NaOH) and potassium hydroxide (KOH) in the environment after supplying current to the circuit, the said compounds allowing for the dissipation/dissolution of the membranes and cell walls of the organisms such as viruses, bacteria, fungi and parasites, developing immunity by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment (1200) and developing immunity by administering the said plasma and/or the plasma which only contains T cells to the body intra venal and introducing them to the components of the immunity system (1300).

Description

A METHOD OF DEVELOPING IMMUNITY BY ADMINISTERING A NEW PLASMA CREATED BY THE RESIDUES OF DEAD BACTERIA, PARASITES AND VIRUSES ETC. LEFT INSIDE THE BLOOD PLASMA AFTER THE PASSAGE OF ELECTRIC CURRENT AS SERUM TO A LIVING BODY
Technical Field:
This invention is related to a method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current without adding any chemicals or performing any additional procedure through the blood plasma taken from the human and animal body infected by organisms such as viruses, bacteria, fungi, parasites etc. as serum to a living body.
Prior Art:
In prior art, immunity is developed when the body beats the infection following vaccination and drug therapy after infections caused by organisms such as viruses, bacteria, fungi, parasites etc. in human and animal blood. However, the fact that it takes a long time to develop and apply vaccines, one of the most important methods used in treatment, does not allow using vaccination on emergency cases and gives rise to the need for other treatment methods.
Another important method used in treatment is drug therapy. However, the fact that the medications used in new types of diseases do not have completely known side effects poses a great risk.
Chemical changes intended in human and animal body are initiated by directly feeding various chemicals to the body in solid, liquid and gas form. To start a chemical reaction, the effect of another chemical is used. In this case, it becomes compulsory to bear with the side effects of these chemicals which might cause unexpected results. Purpose of Invention:
This invention to be registered intends to create chemical reactions inside the plasma by the passage of electric current through the blood plasma taken from human and animal body infected by organisms such as viruses, bacteria, fungi, parasites etc. and thus, allow the plasma to build immunity by deactivating organisms in the plasma such as viruses, bacteria, fungi, parasites etc. Therefore, the plasma acquires a structure that can build immunity in human and animal body and can be administered to human and animal body.
Description of Drawings:
Below is the description of the drawing for the method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body.
Figure 1. The flow chart of the method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body.
Description of References in Drawings:
Below are the descriptions of the reference numbers marked on the flow chart of the method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body. lOO.Creating a circuit configuration through the series connection of a direct current electric generator, an electrical frequency generator, the human or animal blood plasma which functions as a variable resistance module, an on/off switch and the said components together with a conductor wire 2OO.Supplying current to the said circuit until it reaches an energy level that exceeds the molecular bond dissociation energy of water (H2O) and salts of sodium chloride (NaCl) and potassium chloride (KC1) present in the plasma
3OO.As a result of supplying current to the said circuit until it reaches the desired level, dissociation of water (H2O) into hydrogen (H+) and hydroxide (OH ), sodium chloride (NaCl) into (Na+) and chloride (Cl ) and potassium chloride (KC1) into potassium (K+) and chloride (Cl )
400.Bonding of chloride (Cl ) ions created by supplying current to the circuit with oxygen (O) present in dissolved form in the same environment and creating hypochlorite (OC1 ) ion
500.Bonding of hydrogen (H+) created by supplying current to the circuit with hypochlorite (OC1 ) and creating hypochlorous acid (HOC1)
600.Bonding of sodium (Na+) created by supplying current to the circuit with hydroxide (OH ) and creating sodium hydroxide (NaOH)
700.Bonding of potassium (K+) created by supplying current to the circuit and hydroxide (OH ) and creating potassium hydroxide (KOH)
800.Dissolving the lipid bilayer of the viruses in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH) and allowing for the breaking up of the virus bilayer and dissipating the spike proteins which give the virus its infectious character on the bilayer to the environment
900.Dissolving the cell membranes of bacteria, fungi and parasites which have a lipid bilayer present in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH)
1000. Disrupting the cell wall and cytoplasm of bacteria, fungi and parasites present in the plasma by hypochlorous acid (HOC1) and hypochlorite (OCT) and dissipating genetic materials into the environment llOO.Dissolving the capsid protein of the viruses, the lipid bilayer of which is dissolved by sodium hydroxide (NaOH) and potassium hydroxide (KOH), by hypochlorous acid (HOC1) and hypochlorite (OC1 ) and dissipating genetic materials into the plasma environment
1200.Developing immunity by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment
1300.Developing immunity by administering the said plasma and/or the plasma which only contains T cells to the body intra venal and introducing them to the components of the immunity system
Description of Invention:
The invention is a circuit configuration created by using the human or animal plasma as a type of resistance. The said circuit is configured by the series connection of a direct current generator which converts alternating current into direct current, an electrical frequency generator, the human or animal blood plasma which contacts electrodes in a closed insulated nonconductive container, an on/off switch and the said components together with a conductor wire.
The circuit that is created to achieve the purpose of the invention has a direct current electric generator which converts alternating current into direct current. The electrical frequency generator is integrated with a series connection to the direct current electric generator to create a frequency in direct current.
The said circuit has at least one switch that turns the circuit on and off to control the flow of current. The human or animal blood plasma is connected in series to the circuit as resistance to create current intensity in the circuit. In the said circuit, the frequency generator, that gives the current coming from the direct current generator its frequency character and is connected in series to the circuit, is added to the circuit by connecting to the output of the direct current electric generator.
When the said circuit is supplied with current, it reaches an energy level that exceeds the molecular bond dissociation energy of water (H2O) and salts of sodium chloride (NaCl) and potassium chloride (KC1) present in the plasma, and then water (H2O) dissociates into hydrogen (H+) and hydroxide (OH ), sodium chloride (NaCl) into (Na ) and chloride (Cl ) and potassium chloride (KC1) into potassium (K ) and chloride (Ch)
Hypochlorite (OCT) ion is created by the bonding of chloride (Cl ) ions created by supplying current to the circuit with oxygen (O) present in dissolved form in the same environment. Hypochlorous acid (HOC1) is created by the bonding of hydrogen (H+) created by supplying current to the circuit with hypochlorite (OC1 ). Sodium hydroxide (NaOH) is created by the bonding of sodium (Na+) created by supplying current to the circuit with hydroxide (OH ). Potassium hydroxide (KOH) is created by the bonding of potassium (K+) created by supplying current to the circuit with hydroxide (OH ).
Sodium hydroxide (NaOH) and potassium hydroxide (KOH) created by supplying current to the circuit dissolve the lipid bilayer of the viruses in the plasma, allowing for the breaking up of the virus bilayer and dissipating the spike proteins which give the virus its infectious character on the bilayer to the environment. Sodium hydroxide (NaOH) and potassium hydroxide (KOH) created by supplying current to the circuit dissolves the cell membranes of bacteria, fungi and parasites which have a lipid bilayer as cell membrane present in the plasma.
Hypochlorous acid (HOC1) and hypochlorite (OCT) created by supplying current to the circuit disrupt the cell wall and cytoplasm of bacteria, fungi and parasites present in the plasma, dissipating genetic materials into the environment. Hypochlorous acid (HOC1) and hypochlorite (OC1 ) created by supplying current to the circuit dissolve the capsid protein of the viruses the lipid bilayer of which is dissolved and dissipate genetic materials into the plasma environment.
Immunity is developed by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment. Immunity is developed by administering the said plasma to the body intra venal and introducing it to the components of the immunity system.
The method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites and viruses etc. in the blood plasma after the passage of electric current as serum to the body comprises of the following procedural steps:
Creating a circuit configuration through the series connection of a direct current electric generator, an electrical frequency generator, the human or animal blood plasma which functions as a variable resistance module, an on/off switch and the said components together with a conductor wire (100), Supplying current to the said circuit until it reaches an energy level that exceeds the molecular bond dissociation energy of water (H2O) and salts of sodium chloride (NaCl) and potassium chloride (KC1) present in the plasma (200), As a result of supplying current to the said circuit until it reaches the desired level, dissociation of water (H2O) into hydrogen (H+) and hydroxide (OH ), sodium chloride (NaCl) into (Na+) and chloride (Cl ) and potassium chloride (KC1) into potassium (K+) and chloride (Cl ) (300),
Bonding of chloride (Cl ) ions created by supplying current to the circuit with oxygen (O) present in dissolved form in the same environment and creating hypochlorite (OC1 ) ion (400),
Bonding of hydrogen (H+) created by supplying current to the circuit with hypochlorite (OC1 ) and creating hypochlorous acid (HOC1) (500),
Bonding of sodium (Na+) created by supplying current to the circuit with hydroxide (OH ) and creating sodium hydroxide (NaOH) (600),
Bonding of potassium (K+) created by supplying current to the circuit and hydroxide (OH ) and creating potassium hydroxide (KOH) (700),
Dissolving the lipid bilayer of the viruses in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH) and allowing for the breaking up of the virus bilayer and dissipating the spike proteins which give the virus its infectious character on the bilayer to the environment (800), Dissolving the cell membranes of bacteria, fungi and parasites which have a lipid bilayer present in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH) (900),
Disrupting the cell wall and cytoplasm of bacteria, fungi and parasites present in the plasma by hypochlorous acid (HOC1) and hypochlorite (OCT) and dissipating genetic materials into the environment (1000),
Dissolving the capsid protein of the viruses, the lipid bilayer of which is dissolved by sodium hydroxide (NaOH) and potassium hydroxide (KOH), by hypochlorous acid (HOC1) and hypochlorite (OC1 ) and dissipating genetic materials into the plasma environment (1100),
Developing immunity by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment (1200),
Developing immunity by administering the said plasma and/or the plasma which only contains T cells to the body intra venal and introducing them to the components of the immunity system (1300),
Application of Invention to Industry;
The invention is a method used in treatment of humans or animals and can easily be applied to the industry.

Claims

CLAIMS The invention is a method of developing immunity by administering the new plasma created by the residues of dead bacteria, parasites, viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body, and comprising the following procedural steps;
Creating a circuit configuration through the series connection of a direct current electric generator, an electrical frequency generator, the human or animal blood plasma which functions as a variable resistance module, an on/off switch and the said components together with a conductor wire (100), Supplying current to the said circuit until it reaches an energy level that exceeds the molecular bond dissociation energy of water (H2O) and salts of sodium chloride (NaCl) and potassium chloride (KC1) present in the plasma (200), As a result of supplying current to the said circuit until it reaches the desired level, dissociation of water (H2O) into hydrogen (H+) and hydroxide (OH ), sodium chloride (NaCl) into (Na+) and chloride (Cl ) and potassium chloride (KC1) into potassium (K+) and chloride (Cl ) (300),
Bonding of chloride (Cl ) ions created by supplying current to the circuit with oxygen (O) present in dissolved form in the same environment and creating hypochlorite (OC1 ) ion (400),
Bonding of hydrogen (H+) created by supplying current to the circuit with hypochlorite (OC1 ) and creating hypochlorous acid (HOC1) (500),
Bonding of sodium (Na+) created by supplying current to the circuit with hydroxide (OH ) and creating sodium hydroxide (NaOH) (600),
Bonding of potassium (K+) created by supplying current to the circuit and hydroxide (OH ) and creating potassium hydroxide (KOH) (700),
Dissolving the lipid bilayer of the viruses in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH) and allowing for the breaking up of the virus bilayer and dissipating the spike proteins which give the virus its infectious character on the bilayer to the environment (800), Dissolving the cell membranes of bacteria, fungi and parasites which have a lipid bilayer present in the plasma by sodium hydroxide (NaOH) and potassium hydroxide (KOH) (900),
Disrupting the cell wall and cytoplasm of bacteria, fungi and parasites present in the plasma by hypochlorous acid (HOC1) and hypochlorite (OC1 ) and dissipating genetic materials into the environment (1000),
Dissolving the capsid protein of the viruses, the lipid bilayer of which is dissolved by sodium hydroxide (NaOH) and potassium hydroxide (KOH), by hypochlorous acid (HOC1) and hypochlorite (OCT) and dissipating genetic materials into the plasma environment (1100),
Developing immunity by dissipating into the environment the genetic materials from viruses, bacteria, fungi and parasites spreading to the plasma environment as a result of the chemical reactions created by supplying current to the circuit as well as T cells obtained from the human or animal body to the environment (1200),
Developing immunity by administering the said plasma and/or the plasma which only contains T cells to the body intra venal and introducing them to the components of the immunity system (1300).
PCT/TR2021/051047 2020-10-14 2021-10-13 A method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites and viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body WO2022081120A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2020/16418A TR202016418A2 (en) 2020-10-14 2020-10-14 BY PASSING AN ELECTRIC CURRENT OVER THE BLOOD PLASMA, DEAD BACTERIA, PARASITE VIRUSES, ETC. IMMUNITY DEVELOPMENT METHOD BY GIVING THE NEW PLASMA IN WHICH RESIDUALS ARE FORMED TO THE LIVING BODY AS SERUM
TR2020/16418 2020-10-14

Publications (1)

Publication Number Publication Date
WO2022081120A1 true WO2022081120A1 (en) 2022-04-21

Family

ID=81208481

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2021/051047 WO2022081120A1 (en) 2020-10-14 2021-10-13 A method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites and viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body

Country Status (2)

Country Link
TR (1) TR202016418A2 (en)
WO (1) WO2022081120A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560816A (en) * 1994-08-26 1996-10-01 Medical Discoveries, Inc. Method for electrolyzing fluids
US6117285A (en) * 1994-08-26 2000-09-12 Medical Discoveries, Inc. System for carrying out sterilization of equipment
EP1631314A2 (en) * 2003-06-09 2006-03-08 McIntyre, John A. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560816A (en) * 1994-08-26 1996-10-01 Medical Discoveries, Inc. Method for electrolyzing fluids
US6117285A (en) * 1994-08-26 2000-09-12 Medical Discoveries, Inc. System for carrying out sterilization of equipment
EP1631314A2 (en) * 2003-06-09 2006-03-08 McIntyre, John A. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions

Also Published As

Publication number Publication date
TR202016418A2 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
JP3179111B2 (en) Fluid electrolysis system for in vivo administration to humans and other warm-blooded animals
JP6802224B2 (en) Water electrolyzer
KR102218817B1 (en) An electrolyzed water generating method and a generator
AU2006241025A1 (en) Apparatus for manufacturing sterilized water, spraying apparatus thereof, and capsule containing salt using therein
Mohammed et al. 2019 novel coronavirus disease (covid-19): Toward a novel design for disinfection robot to combat coronavirus (covid-19) using iot based technology
JP5221591B2 (en) How to control ectoparasites that infest cultured fish
WO2022081120A1 (en) A method of developing immunity by administering a new plasma created by the residues of dead bacteria, parasites and viruses etc. left inside the blood plasma after the passage of electric current as serum to a living body
US20230398256A1 (en) An integrated air, liquid and surface sterilization method and system thereof
US20160222526A1 (en) Devices and methods for electrolytic production of disinfectant solution from salt solution in a container
US20230347149A1 (en) Method of electrochemical separation of membranes of viruses with lipids that cause infection in human and animals
JP7139344B2 (en) System for water disinfection using electroporation
JP2015178061A (en) Electrolytic water generator
KR20160002488U (en) a device making sterilizable water using electrolysis
CN109715565A (en) The separation discharger for the gas particle that water electrolysis generates
CN103204563A (en) Preparation method for disinfectant fluid based on low temperature plasma
KR20170132980A (en) Device for generating hydrogen water
JP6675112B2 (en) Electrolysis raw water storage type electrolyzer
WO2021251928A2 (en) A treatment method about using the human body as a variable resistance module
CN208598072U (en) A kind of water purifying and disinfection water two-purpose cup
KR200436024Y1 (en) Foot Bathtub Using Difference of Metal Ionization Drift
CN102477563A (en) Preparation device for medical electron-particle effect disinfector
WO2022060327A2 (en) Method of forming chloride ion (c1-), hypochlorite ion (oc1-) and hypochlorous acid (hoc1) in the human and animal body
ES2887943A1 (en) WATER IONIZER FOR DISINFECTION OF INDUSTRIAL SURFACES (Machine-translation by Google Translate, not legally binding)
JP2011088149A (en) Method of preparing electrolyzed water and composition
CN114409023A (en) Neutral plasma activated water preparation device and method based on ion exchange membrane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21880695

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 07/06/2023)

122 Ep: pct application non-entry in european phase

Ref document number: 21880695

Country of ref document: EP

Kind code of ref document: A1